- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 222.6M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 227.45M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 223.62M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $10.7M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $0 |
| Capex | Q1 2026 · Mar 31, 2026 | $260.02M |
| Capex | Q1 2026 · Mar 31, 2025 | $142.48M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $198.79M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $183.86M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $1.48B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $1.49B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $20.71M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $21.85M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $119.95M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $204.81M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3.22B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $3.13B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $2.73B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $2.61B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $608.68M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $609.51M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $4.89B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.88B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $323M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $385.76M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $8.11B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $8.01B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.39 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.34 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.40 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.36 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $59.63M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $57.85M |
| Net Income | Q1 2026 · Mar 31, 2026 | $88.1M |
| Net Income | Q1 2026 · Mar 31, 2025 | $76.14M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $134.84M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $107.67M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $406.7M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $370.99M |
| Revenue | Q1 2026 · Mar 31, 2026 | $788.7M |
| Revenue | Q1 2026 · Mar 31, 2025 | $706.04M |